Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. (Q39115606)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 February 2017

Language	Label	Description	Also known as
English	Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.	scientific article published on 2 February 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

0 references

1 reference

based on heuristic

inferred from title

rhinoconjunctivitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

allergic asthma

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Erika Jensen-Jarolim

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Edward Frank Knol

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Carsten B Schmidt-Weber

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Stephen R Durham

16

object named as

S R Durham

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

author name string

J H Kappen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

M Akdis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

J Kleine-Tebbe

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

A M Chaker

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

R Valenta

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

L K Poulsen

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

M A Calderon

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

P Demoly

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

L Jacobsen

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

publication date

6 April 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

72

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1156-1173

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

International consensus on allergy immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Systematic reviews of sublingual immunotherapy (SLIT).

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

An update on allergen immunotherapy and asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Mechanisms of immunotherapy to aeroallergens

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Allergen immunotherapy and tolerance

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Toward precision medicine and health: Opportunities and challenges in allergic diseases

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

A comparative analysis of symptom and medication scoring methods used in clinical trials of sublingual immunotherapy for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Allergen immunotherapy: A practice parameter third update

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Initial immunological changes as predictors for house dust mite immunotherapy response.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

A long-term follow-up study of hyposensitization with immunoblotting.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Monitoring Allergen Immunotherapy Effects by Microarray

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Mechanism of immunoglobulin G4 Fab-arm exchange

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

IgG4 breaking the rules

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

SEROLOGICAL EVIDENCE OF IMMUNITY WITH COEXISTING SENSITIZATION IN A TYPE OF HUMAN ALLERGY (HAY FEVER).

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Antibody response following immunotherapy in ragweed hay fever: Allpyral vs. whole ragweed extract

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Performance evaluation of a specific IgE assay developed for the ADVIA centaur® immunoassay system

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Cell-free detection of allergen-IgE cross-linking with immobilized phase CD23: inhibition by blocking antibody responses after immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

The role of basophils in the pathogenesis of allergic disease

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

The role of the basophil in allergic inflammation

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

CD-sens: a biological measure of immunological changes stimulated by ASIT.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Impaired secretion of interleukin-4 and interleukin-13 by allergen-specific T cells correlates with defective nuclear expression of NF-AT2 and jun B: relevance to immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Adipokines and sublingual immunotherapy: preliminary report.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Apolipoprotein A-IV is a candidate target molecule for the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Functional regulatory T cells and allergen immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Advances in allergen immunotherapy: aiming for complete tolerance to allergens

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Immune regulatory function of B cells.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Allergen immunotherapy: clinical outcomes assessment

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

In vivo diagnosis of allergic diseases--allergen provocation tests

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Diagnostic tools in Rhinology EAACI position paper

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Responses to ragweed-pollen nasal challenge before and after immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Local and systemic effects of cat allergen nasal provocation.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Environmental exposure chambers in allergen immunotherapy trials: Current status and clinical validation needs

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

House dust mite sublingual immunotherapy: results of a US trial

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Clinico-immunological changes post-immunotherapy with Periplaneta americana.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Association between specific timothy grass antigens and changes in TH1- and TH2-cell responses following specific immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Effect of Japanese cedar specific immunotherapy on allergen-specific T(H)2 cells in peripheral blood

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Immunologic response to administration of standardized dog allergen extract at differing doses.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Clinical and cytokine responses to house dust mite sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

T lymphocytes expressing CCR3 are increased in allergic rhinitis compared with non-allergic controls and following allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Evaluation of clinical and immunological responses: a 2-year follow-up study in children with allergic rhinitis due to house dust mite.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Immunological Effects of Sublingual Immunotherapy: Clinical Efficacy Is Associated with Modulation of Programmed Cell Death Ligand 1, IL-10, and IgG4

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes

1 reference

https://api.crossref.org/works/10.1111%2FALL.13138

21 January 2018

Identifiers

10.1111/ALL.13138

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28152201%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39115606&oldid=1525135809"